Predicting severe outcomes in autoimmune encephalitis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study is building a tool to predict which patients with autoimmune encephalitis will become severely ill. It looks at certain factors in your blood and spinal fluid to help doctors plan better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 14 to 80 years old.
- You have been clearly diagnosed with autoimmune encephalitis, including knowing which antibody is causing it.
- Your diagnosis happened within the last 3 months.
- You have had a lumbar puncture (spinal tap) to check the fluid around your brain and spine for antibodies.
- You have already received immunotherapy (like steroids) for your condition.
- Before you got sick, you were mostly independent in daily activities – not needing significant help to walk or care for yourself.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at adults with autoimmune encephalitis who needed care in the intensive care unit (ICU). It aims to find patterns and markers that help predict how patients will do.
This study is for people with autoimmune encephalitis, a condition where the immune system attacks the brain. It aims to collect information about this disease to learn more about it and how to treat it.
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
This study follows patients with autoimmune encephalitis (brain inflammation caused by the immune system) to see how treatments affect them in the medium term. It may help doctors learn which treatments work best for people with this condition.
This study tests a natural bile-derived medicine (Calcus Bovis Sativus) to see if it can help adults with new or recent brain inflammation (encephalitis). It focuses on people whose encephalitis is caused by the immune system or a virus, and who have not fully recovered.
This study tests whether an experimental treatment using tiny particles from stem cells (called exosomes) given through the nose can help people with autoimmune encephalitis. It is for adults who were recently diagnosed and have specific antibodies.
Hear when a new Severe Autoimmune Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.